Verition Fund Management LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $3.7 Million - $4.07 Million	4,100 Added 141.38%	7,000 $6.74 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $2.02 Million - $2.29 Million	2,600 Added 866.67%	2,900 $2.55 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $553,960 - $675,496	-800 Reduced 72.73%	300 $246,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $770,033 - $913,385	1,100 New	1,100 $790,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $211,767 - $229,917	-300 Reduced 5.56%	5,100 $3.68 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $3.1 Million - $3.91 Million	5,400 New	5,400 $3.72 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $595,120 - $698,430	1,000 Added 18.52%	6,400 $4.47 Million
Q4 2021 May 03, 2022	BUY	$543.48 - $670.97 $2.93 Million - $3.62 Million	5,400 New	5,400 $3.41 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.